$ALT
Altimmune, Inc. Stock $alt

$alt Overview Financials Valuation SEC Filings Company Website

2017 Q3 Form 10-Q Financial Statement

#000119312517256136 Filed on August 14, 2017

Income Statement

Concept	2017 Q3	2017 Q2	2016 Q2
Revenue	$4.592M	$3.038M	$746.0K
YoY Change	409.63%	307.25%	-35.13%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$3.040M	$1.790M	$820.0K
YoY Change	-7.6%	118.29%	-54.95%
% of Gross Profit
Research & Development	$5.906M	$5.255M	$1.382M
YoY Change	145.97%	280.36%	13.0%
% of Gross Profit
Depreciation & Amortization	$30.00K	$50.00K	$40.44K
YoY Change	-6.93%	23.66%	10.22%
% of Gross Profit
Operating Expenses	$35.54M	$7.049M	$2.348M
YoY Change	524.62%	200.2%	-24.6%
Operating Profit	-$30.95M	-$4.011M	-$1.602M
YoY Change	546.25%	150.36%	-18.46%
Interest Expense	$2.344K	$97.16K	$9.618K
YoY Change	-75.09%	910.15%	-27.57%
% of Operating Profit
Other Income/Expense, Net	-$485.7K	-$92.83K	-$14.88K
YoY Change	8671.16%	523.7%	-95.92%
Pretax Income	-$31.44M	-$4.104M	-$1.617M
YoY Change	555.63%	153.8%	-30.59%
Income Tax	-$1.533M	-$993.7K	$15.44K
% Of Pretax Income
Net Earnings	-$29.91M	-$3.110M	-$1.617M
YoY Change	523.67%	92.35%	-30.92%
Net Earnings / Revenue	-651.25%	-102.38%	-216.78%
Basic Earnings Per Share			$0.12
Diluted Earnings Per Share	-$57.52M	-$7.585M	$0.12
COMMON SHARES
Basic Shares Outstanding	15.42M shares	68.82M shares	64.74M shares
Diluted Shares Outstanding			65.21M shares

Balance Sheet

Concept	2017 Q3	2017 Q2	2016 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$17.10M	$8.400M	$23.20M
YoY Change	-87.42%	-63.79%	26.09%
Cash & Equivalents	$17.12M	$8.368M	$23.16M
Short-Term Investments			$6.400M
Other Short-Term Assets	$1.000M	$1.400M	$400.0K
YoY Change	100.0%	250.0%	33.33%
Inventory
Prepaid Expenses
Receivables	$2.900M	$3.600M	$1.800M
Other Receivables	$5.100M	$3.500M	$0.00
Total Short-Term Assets	$26.12M	$17.00M	$25.40M
YoY Change	-81.08%	-33.09%	27.6%
LONG-TERM ASSETS
Property, Plant & Equipment	$280.1K	$293.2K	$183.7K
YoY Change	82.09%	59.63%	-40.41%
Goodwill	$9.335M	$35.40M	$2.348M
YoY Change	297.49%	1407.33%	0.0%
Intangibles	$38.59M	$38.13M
YoY Change
Long-Term Investments
YoY Change
Other Assets	$22.25K	$22.25K	$0.00
YoY Change			-100.0%
Total Long-Term Assets	$48.22M	$73.85M	$2.532M
YoY Change	1827.19%	2816.37%	-6.57%
TOTAL ASSETS
Total Short-Term Assets	$26.12M	$17.00M	$25.40M
Total Long-Term Assets	$48.22M	$73.85M	$2.532M
Total Assets	$74.35M	$90.84M	$27.93M
YoY Change	-47.1%	225.24%	23.5%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$495.1K	$1.131M	$711.1K
YoY Change	-19.44%	59.02%	241.13%
Accrued Expenses	$3.600M	$4.300M	$1.700M
YoY Change	80.0%	152.94%	-37.04%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change			-100.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$4.180M	$5.528M	$3.269M
YoY Change	12.12%	69.12%	-0.95%
LONG-TERM LIABILITIES
Long-Term Debt	$600.0K	$600.0K	$0.00
YoY Change
Other Long-Term Liabilities	$4.200M	$200.0K	$411.6K
YoY Change	883.43%	-51.41%	-54.26%
Total Long-Term Liabilities	$4.800M	$800.0K	$411.6K
YoY Change	1023.92%	94.34%	-54.26%
TOTAL LIABILITIES
Total Short-Term Liabilities	$4.180M	$5.528M	$3.269M
Total Long-Term Liabilities	$4.800M	$800.0K	$411.6K
Total Liabilities	$17.28M	$14.87M	$3.680M
YoY Change	315.77%	303.93%	-14.41%
SHAREHOLDERS EQUITY
Retained Earnings	-$68.85M	-$38.95M	-$216.9M
YoY Change	-36.05%	-82.04%
Common Stock	$1.563K	$1.542K	$6.479K
YoY Change	-76.47%	-76.2%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$48.83M	$75.98M	$24.25M
YoY Change
Total Liabilities & Shareholders Equity	$74.35M	$90.84M	$27.93M
YoY Change	-47.1%	225.24%	23.59%

Cashflow Statement

Concept	2017 Q3	2017 Q2	2016 Q2
OPERATING ACTIVITIES
Net Income	-$29.91M	-$3.110M	-$1.617M
YoY Change	523.67%	92.35%	-30.92%
Depreciation, Depletion And Amortization	$30.00K	$50.00K	$40.44K
YoY Change	-6.93%	23.66%	10.22%
Cash From Operating Activities	-$4.260M	-$7.810M	$8.540M
YoY Change	-64.62%	-191.45%	222.26%
INVESTING ACTIVITIES
Capital Expenditures	-$30.00K	-$50.00K	-$30.00K
YoY Change	-80.0%	66.67%	50.0%
Acquisitions
YoY Change
Other Investing Activities	$10.00K	$13.68M	$0.00
YoY Change
Cash From Investing Activities	-$20.00K	$13.63M	-$30.00K
YoY Change	-86.67%	-45533.33%	50.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	12.99M	-200.0K	420.0K
YoY Change	148.37%	-147.62%	740.0%
NET CHANGE
Cash From Operating Activities	-4.260M	-7.810M	8.540M
Cash From Investing Activities	-20.00K	13.63M	-30.00K
Cash From Financing Activities	12.99M	-200.0K	420.0K
Net Change In Cash	8.710M	5.620M	8.930M
YoY Change	-225.14%	-37.07%	233.21%
FREE CASH FLOW
Cash From Operating Activities	-$4.260M	-$7.810M	$8.540M
Capital Expenditures	-$30.00K	-$50.00K	-$30.00K
Free Cash Flow	-$4.230M	-$7.760M	$8.570M
YoY Change	-64.42%	-190.55%	220.97%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2017Q2	us-gaap	Business Acquisition Cost Of Acquired Entity Transaction Costs BusinessAcquisitionCostOfAcquiredEntityTransactionCosts	1673695
CY2017Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2017Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	15422913	shares
CY2016Q1	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	343114	shares
CY2017Q1	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	666546	shares
CY2016Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	5126647
CY2016Q2	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	477613	shares
CY2017Q2	us-gaap	Assets Current AssetsCurrent	16995600
CY2017Q2	us-gaap	Accrued Professional Fees Current And Noncurrent AccruedProfessionalFeesCurrentAndNoncurrent	256737
CY2017Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	120661697
CY2017Q2	us-gaap	Restricted Cash Current RestrictedCashCurrent	34174
CY2017Q2	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	49776	shares
CY2017Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2017Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	15452579	shares
CY2017Q2	us-gaap	Common Stock Value CommonStockValue	1542
CY2017Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	52320
CY2017Q2	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	940080
CY2017Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	482172
CY2017Q2	us-gaap	Goodwill Goodwill	35398960
CY2017Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	41612
CY2017Q2	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	3573131
CY2017Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	1130797
CY2017Q2	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	3571703
CY2017Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-5738006
CY2017Q2	us-gaap	Assets Assets	90842306
CY2017Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	8367774
CY2017Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	8401948
CY2017Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2017Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2017Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	15424891	shares
CY2017Q2	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.01
CY2017Q2	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	4658	shares
CY2017Q2	us-gaap	Deferred Compensation Cashbased Arrangements Liability Classified Noncurrent DeferredCompensationCashbasedArrangementsLiabilityClassifiedNoncurrent	372
CY2017Q2	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	32253
CY2017Q2	us-gaap	Deferred Rent Credit Noncurrent DeferredRentCreditNoncurrent	6366
CY2017Q2	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	8544195
CY2017Q2	us-gaap	Deferred Rent Credit Current DeferredRentCreditCurrent	17213
CY2017Q2	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	169547
CY2017Q2	us-gaap	Due To Officers Or Stockholders Noncurrent DueToOfficersOrStockholdersNoncurrent	106930
CY2017Q2	us-gaap	Employee Related Liabilities Current And Noncurrent EmployeeRelatedLiabilitiesCurrentAndNoncurrent	555170
CY2017Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	457908
CY2017Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	34075
CY2017Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	293129
CY2017Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	13515
CY2017Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	47521
CY2017Q2	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	536
CY2017Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	38132266
CY2017Q2	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	38590174
CY2017Q2	us-gaap	Liabilities Liabilities	14865686
CY2017Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	90842306
CY2017Q2	us-gaap	Liabilities Current LiabilitiesCurrent	5527961
CY2017Q2	us-gaap	Long Term Debt LongTermDebt	570545
CY2017Q2	us-gaap	Notes Payable Current NotesPayableCurrent	49702
CY2017Q2	us-gaap	Other Long Term Debt Noncurrent OtherLongTermDebtNoncurrent	46700
CY2017Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	22247
CY2017Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1448818
CY2017Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	293233
CY2016Q4	us-gaap	Deferred Rent Credit Noncurrent DeferredRentCreditNoncurrent	15914
CY2017Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-38948613
CY2017Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	2061156
CY2017Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	9.51
CY2017Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	17256
CY2017Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	325124	shares
CY2017Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	2078412
CY2017Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	1144535	shares
CY2017Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	6.21
CY2017Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1469659	shares
CY2017Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	6.94
CY2017Q2	us-gaap	Stockholders Equity StockholdersEquity	75976620
CY2017Q2	alt	Accrued Expenses And Other Current Liabilities AccruedExpensesAndOtherCurrentLiabilities	4297996
CY2017Q2	alt	Accrued Research And Development AccruedResearchAndDevelopment	3378623
CY2015Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	4638711
CY2015Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	208614	shares
CY2016Q4	us-gaap	Assets Current AssetsCurrent	4487090
CY2016Q4	us-gaap	Accrued Professional Fees Current And Noncurrent AccruedProfessionalFeesCurrentAndNoncurrent	689135
CY2016Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	71034899
CY2016Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	2005208
CY2016Q4	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	383046
CY2016Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-7574812
CY2016Q4	us-gaap	Assets Assets	38400335
CY2016Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2876113
CY2016Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2876113
CY2016Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2016Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2016Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	6917204	shares
CY2016Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	616770	shares
CY2016Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2016Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	6986780	shares
CY2016Q4	us-gaap	Common Stock Value CommonStockValue	692
CY2016Q4	us-gaap	Deferred Compensation Cashbased Arrangements Liability Classified Noncurrent DeferredCompensationCashbasedArrangementsLiabilityClassifiedNoncurrent	1001
CY2016Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	19753
CY2016Q4	us-gaap	Deferred Rent Credit Current DeferredRentCreditCurrent	14388
CY2016Q4	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	179424
CY2016Q4	us-gaap	Due To Officers Or Stockholders Noncurrent DueToOfficersOrStockholdersNoncurrent	606199
CY2016Q4	us-gaap	Employee Related Liabilities Current And Noncurrent EmployeeRelatedLiabilitiesCurrentAndNoncurrent	957719
CY2016Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	431756
CY2016Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	909454
CY2016Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	477698
CY2016Q4	us-gaap	Goodwill Goodwill	18758421
CY2016Q4	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	807507
CY2016Q4	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	169790
CY2016Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	14954717
CY2016Q4	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	15386473
CY2016Q4	us-gaap	Liabilities Liabilities	6193012
CY2016Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	38400335
CY2016Q4	us-gaap	Liabilities Current LiabilitiesCurrent	5470723
CY2016Q4	us-gaap	Long Term Debt LongTermDebt	525950
CY2016Q4	us-gaap	Notes Payable Current NotesPayableCurrent	458629
CY2016Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	22248
CY2016Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	420424
CY2016Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	177859
CY2016Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-31259449
CY2016Q4	us-gaap	Stockholders Equity StockholdersEquity	32207323
CY2016Q4	alt	Accrued Expenses And Other Current Liabilities AccruedExpensesAndOtherCurrentLiabilities	2972745
CY2016Q4	alt	Accrued Research And Development AccruedResearchAndDevelopment	549902
CY2017Q2	us-gaap	Conversion Of Stock Shares Converted1 ConversionOfStockSharesConverted1	8539263	shares
CY2017Q2	us-gaap	Debt Instrument Convertible Number Of Equity Instruments DebtInstrumentConvertibleNumberOfEquityInstruments	316735	pure
CY2017Q2	alt	Discount Rate To Determine Present Value Of Cash Flow DiscountRateToDeterminePresentValueOfCashFlow	0.23	pure
	us-gaap	Adjustment For Amortization AdjustmentForAmortization	26152
	dei	Amendment Flag AmendmentFlag	false
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	684088
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	98060
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	5525835
	us-gaap	Cash Acquired From Acquisition CashAcquiredFromAcquisition	13684535
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-5852358
	us-gaap	Debt Conversion Converted Instrument Warrants Or Options Issued1 DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1	49776	shares
	us-gaap	Decrease In Restricted Cash DecreaseInRestrictedCash	200000
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	566793
	us-gaap	Depreciation Depreciation	37827
	us-gaap	Dividends Preferred Stock Stock DividendsPreferredStockStock	163069
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	0.82
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2017
	dei	Document Type DocumentType	10-Q
	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	51553
	dei	Document Period End Date DocumentPeriodEndDate	2017-06-30
	dei	Entity Registrant Name EntityRegistrantName	ALTIMMUNE, INC.
	dei	Entity Central Index Key EntityCentralIndexKey	0001326190
	dei	Entity Filer Category EntityFilerCategory	Smaller Reporting Accelerated Filer
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-3523
	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	15623057
	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	2200000
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3825026
	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	1017482
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-8682873
	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	15822
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	2623
	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	725106
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	2064194
	us-gaap	Increase Decrease In Prepaid Rent IncreaseDecreaseInPrepaidRent	8136
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-993709
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-1627477
	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	716649
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	588251
	us-gaap	Interest Expense InterestExpense	157759
	us-gaap	Investment Income Interest InvestmentIncomeInterest	4166
	us-gaap	Interest Paid InterestPaid	5030
	us-gaap	License And Services Revenue LicenseAndServicesRevenue	9876
	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	13770011
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-11149228
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-7852233
	us-gaap	Number Of Reporting Units NumberOfReportingUnits	1	Reporting_Unit
	us-gaap	Operating Expenses OperatingExpenses	11865877
	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	Segment
	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	2853499
	us-gaap	Operating Income Loss OperatingIncomeLoss	-8528333
	us-gaap	Net Income Loss NetIncomeLoss	-7689164
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-154540
	us-gaap	Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax	-1836806
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-947
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	30626
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	83898
	us-gaap	Proceeds From Debt Net Of Issuance Costs ProceedsFromDebtNetOfIssuanceCosts	3018780
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	450
	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	46700
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	212431
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	8040851
	us-gaap	Revenue From Grants RevenueFromGrants	3327668
	us-gaap	Sales Revenue Net SalesRevenueNet	3337544
	us-gaap	Share Based Compensation ShareBasedCompensation	684088
	dei	Trading Symbol TradingSymbol	ALT
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	9596423	shares
	alt	Number Of Warrants Exercised For Conversion Of Securities NumberOfWarrantsExercisedForConversionOfSecurities	661888	shares
	alt	Exchange Of Stock ExchangeOfStock	1-for-1 basis
	alt	Accrued Expenses And Conversion Of Note Payable To Convertible Notes AccruedExpensesAndConversionOfNotePayableToConvertibleNotes	1077540
	alt	Estimated Average Market Fair Value Of Intangible Assets EstimatedAverageMarketFairValueOfIntangibleAssets	50900000
	alt	Reporting Unit Carrying Amount ReportingUnitCarryingAmount	76000000
	alt	Impairment Adjustments ImpairmentAdjustments	0
	alt	Hypothetical Downward Adjustment Percentage Of Range Of Control Premium HypotheticalDownwardAdjustmentPercentageOfRangeOfControlPremium	0.10	pure
	us-gaap	Adjustment For Amortization AdjustmentForAmortization	48788
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	389729
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	487936
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-7034220
	us-gaap	Debt Conversion Converted Instrument Warrants Or Options Issued1 DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1	268999	shares
	us-gaap	Depreciation Depreciation	29726
	us-gaap	Dividends Preferred Stock Stock DividendsPreferredStockStock	143014
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.49
	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	-100082
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2011797
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-3229926
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-47137
	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	87584
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-206273
	us-gaap	Increase Decrease In Prepaid Rent IncreaseDecreaseInPrepaidRent	3981
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	122918
	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	-440139
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-44533
	us-gaap	Interest Expense InterestExpense	19248
	us-gaap	Investment Income Interest InvestmentIncomeInterest	845
	us-gaap	Interest Paid InterestPaid	1662
	us-gaap	License And Services Revenue LicenseAndServicesRevenue	163403
	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-59898
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-2966800
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-3372940
	us-gaap	Operating Expenses OperatingExpenses	4455928
	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	3614716
	us-gaap	Net Income Loss NetIncomeLoss	-3229926
	us-gaap	Operating Income Loss OperatingIncomeLoss	-3205052
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-24874
	us-gaap	Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax	3804294
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-6471
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	47374
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	12524
	us-gaap	Proceeds From Debt Net Of Issuance Costs ProceedsFromDebtNetOfIssuanceCosts	531
	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock	3673790
	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	260000
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	99
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2444131
	us-gaap	Revenue From Grants RevenueFromGrants	1087473
	us-gaap	Sales Revenue Net SalesRevenueNet	1250876
	us-gaap	Share Based Compensation ShareBasedCompensation	389729
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	6911189	shares
	alt	Payment Of Deferred Offering Costs PaymentOfDeferredOfferingCosts	319506
	alt	Preferred Stock Issuance Reclassified As Additional Paid In Capital PreferredStockIssuanceReclassifiedAsAdditionalPaidInCapital	325280
CY2016Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	227383
CY2016Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-4231290
CY2016Q2	us-gaap	Debt Conversion Converted Instrument Warrants Or Options Issued1 DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1	134499	shares
CY2016Q2	us-gaap	Dividends Preferred Stock Stock DividendsPreferredStockStock	87123
CY2016Q2	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.25
CY2016Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	966641
CY2016Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1617070
CY2016Q2	us-gaap	Interest Expense InterestExpense	9618
CY2016Q2	us-gaap	Investment Income Interest InvestmentIncomeInterest	845
CY2016Q2	us-gaap	License And Services Revenue LicenseAndServicesRevenue	158465
CY2016Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-1704193
CY2016Q2	us-gaap	Operating Expenses OperatingExpenses	2348154
CY2016Q2	us-gaap	Net Income Loss NetIncomeLoss	-1617070
CY2016Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-1602187
CY2016Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-14883
CY2016Q2	us-gaap	Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax	2614220
CY2016Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-6110
CY2016Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1381513
CY2016Q2	us-gaap	Revenue From Grants RevenueFromGrants	587502
CY2016Q2	us-gaap	Sales Revenue Net SalesRevenueNet	745967
CY2016Q2	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	6911189	shares
CY2017Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	338987
CY2017Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-1853412
CY2017Q2	us-gaap	Dividends Preferred Stock Stock DividendsPreferredStockStock	44713
CY2017Q2	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.26
CY2017Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1794509
CY2017Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-4104091
CY2017Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-993709
CY2017Q2	us-gaap	Interest Expense InterestExpense	97156
CY2017Q2	us-gaap	Investment Income Interest InvestmentIncomeInterest	4166
CY2017Q2	us-gaap	License And Services Revenue LicenseAndServicesRevenue	4938
CY2017Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-3155095
CY2017Q2	us-gaap	Operating Expenses OperatingExpenses	7049238
CY2017Q2	us-gaap	Net Income Loss NetIncomeLoss	-3110382
CY2017Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-4011265
CY2017Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-92826
CY2017Q2	us-gaap	Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax	-1256970
CY2017Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	164
CY2017Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	5254729
CY2017Q2	us-gaap	Revenue From Grants RevenueFromGrants	3033035
CY2017Q2	us-gaap	Sales Revenue Net SalesRevenueNet	3037973
CY2017Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P5Y4M20D
CY2017Q2	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	12245701	shares
CY2017Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P3Y2M5D
CY2017Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P2Y6M18D
CY2017Q2	alt	Number Of Warrants Exercised For Conversion Of Securities NumberOfWarrantsExercisedForConversionOfSecurities	661888	shares

Files In Submission

Name	View Source	Status
0001193125-17-256136-index-headers.html	Edgar Link	pending
0001193125-17-256136-index.html	Edgar Link	pending
0001193125-17-256136.txt	Edgar Link	pending
0001193125-17-256136-xbrl.zip	Edgar Link	pending
alt-20170630.xml	Edgar Link	completed
alt-20170630.xsd	Edgar Link	pending
alt-20170630_cal.xml	Edgar Link	unprocessable
alt-20170630_def.xml	Edgar Link	unprocessable
alt-20170630_lab.xml	Edgar Link	unprocessable
alt-20170630_pre.xml	Edgar Link	unprocessable
d408900d10q.htm	Edgar Link	pending
d408900dex1010.htm	Edgar Link	pending
d408900dex1011.htm	Edgar Link	pending
d408900dex1012.htm	Edgar Link	pending
d408900dex1013.htm	Edgar Link	pending
d408900dex1014.htm	Edgar Link	pending
d408900dex1015.htm	Edgar Link	pending
d408900dex1016.htm	Edgar Link	pending
d408900dex1017.htm	Edgar Link	pending
d408900dex1018.htm	Edgar Link	pending
d408900dex1019.htm	Edgar Link	pending
d408900dex106.htm	Edgar Link	pending
d408900dex107.htm	Edgar Link	pending
d408900dex108.htm	Edgar Link	pending
d408900dex109.htm	Edgar Link	pending
d408900dex311.htm	Edgar Link	pending
d408900dex312.htm	Edgar Link	pending
d408900dex321.htm	Edgar Link	pending
d408900dex322.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
g4089001aa.jpg	Edgar Link	pending
g408900ie1.jpg	Edgar Link	pending
g408900ie2.jpg	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$ALT
Altimmune, Inc. Stock $alt

2017 Q3 Form 10-Q Financial Statement

#000119312517256136 Filed on August 14, 2017

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ALT Altimmune, Inc. Stock $alt

2017 Q3 Form 10-Q Financial Statement

#000119312517256136 Filed on August 14, 2017

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ALT
Altimmune, Inc. Stock $alt